Through tireless work and reinvesting profits back into our company, we developed new products and earned recognition and praise from the industry. As we look to the future, we aim to continue pushing the boundaries of innovation and excellence in our industry, with the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
You are here: Home / News
IGF-1 (Insulin-like Growth Factor 1) Test

What is an IGF-1 test?This test measures the amount of IGF-1 (insulin-like growth factor 1) in your blood. IGF-1 is a hormone that manages the effects of growth hormone (GH) in your body. Together, IGF-1 and GH promote normal growth of bones and tissues. GH levels in the blood fluctuate throughout the day depending on your diet and activity levels. But IGF-1 levels remain stable. So, an IGF-1 test is a useful way to find out if your body is making a normal amount of GH.

02/ 14 / 2024
Rapid Diagnostic Test for Respiratory Infections

With the onset of winter, there is an increase in acute respiratory infections caused by various respiratory pathogens recently. As in other infectious processes, swift accurate diagnosis is associated with more targeted and effective treatment, lower transmission of the disease and, often, a reduction in its duration. To combat rise of acute respiratory infections, Medlere provides rapid quantitative tests for respiratory infections basing on immunofluorescence technology, which delivers rapid and accurate results within minutes. • RSV (Respiratory Syncytial Virus) • ADV (Adenovirus) • Influenza A/B • SARS-CoV-2 • SARS-CoV-2/InfluenzaA/B • Mycoplasmsa Pneumoniae

12/ 01 / 2023
The Crucial Role of Immunofluorescence Assay in the IVD Industry

Medlere's Fluorescence Immunoassay sets a new standard for Point-of-Care Testing (POCT) solutions. This system delivers rapid and accurate results within minutes. Designed with user-friendliness in mind, our Fluorescence Immunoassay empowers healthcare professionals with a reliable tool to diagnose a wide range of diseases and conditions, elevating patient care and treatment outcomes.

03/ 28 / 2022
Medlere Limited's Factory in China Now Operational, Marking a Significant Milestone

Medlere Limited, a leading healthcare technology company, is excited to announce the successful completion and commencement of operations at its state-of-the-art factory in China. This achievement represents a major milestone in Medlere Limited's global expansion strategy and reaffirms its commitment to delivering cutting-edge healthcare solutions to clients worldwide.

07/ 28 / 2021
Medlere Limited Establishes Subsidiary in China to Expand Global Supply Chain and Provide World-Class In Vitro Diagnostic Services

Medlere Limited, a prominent healthcare technology company based in the United Kingdom, is thrilled to announce the establishment of its subsidiary in China. This strategic move represents a significant step in the company's mission to establish a robust supply chain system in China and offer cutting-edge in vitro diagnostic services to clients worldwide.

06/ 13 / 2020

Who We Are

With the ultimate goal of making a positive impact on the health and wellbeing of people everywhere.
Contact Us
Address: 291 Brighton Road South Croydon United Kingdom Cr2 6Eq    E-mail:    Tel.: +447565748991
The content on the Medlere website may showcase some of our forthcoming care offerings, which are currently under development. Please note that these offerings are subject to completion of the development process and may require regulatory authorization, clearance, or approval before they can be made available for commercial use.
@​2023 Medlere Limited. All Rights Reserved.